Help | RSS Feed

Astellas Pharma, Inc. (OTCMKT:ALPMY) Seasonal Chart

Astellas Pharma, Inc. (OTCMKT:ALPMY) Seasonality

ALPMY Relative to the S&P 500
ALPMY Relative to the S&P 500

ALPMY Relative to the Sector
ALPMY Relative to the Sector

Monthly Seasonal Astellas Pharma, Inc. (OTCMKT:ALPMY)

Seasonal Chart Analysis

Analysis of the Astellas Pharma, Inc. (OTCMKT:ALPMY) seasonal charts above shows that a Buy Date of June 6 and a Sell Date of August 25 has resulted in a geometric average return of 8.3% above the benchmark rate of the S&P 500 Total Return Index over the past 8 years. This seasonal timeframe has shown positive results compared to the benchmark in 8 of those periods. This is an excellent rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 8 years by an average of 14.39% per year.

The seasonal timeframe is Inline with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

A word of caution: Only 8 years of data is available for shares of ALPMY, perhaps insufficient to create a seasonal profile that accurately gauges the seasonal tendencies influencing the investment. Ideally, while 20 years is preferred, at least 10 years of data is required to perform a seasonal analysis that is considered to be reliable for future seasonal periods.

Astellas Pharma Inc is a drug manufacturer with a focus on oncology based in Japan. It sells its pharmaceutical products across the world with Japan, Americas, EMEA, and Asia & Oceania being its main business regions.

Stocks mentioned in this post:

    Search Seasonal Charts by Symbol, Company, or Term

   Symbols by Letter: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Sponsored By...
Seasonal Advantage Portfolio by CastleMoore